Research
Education
Healthcare
Community
About
Aug 25, 2023 | Orange Coast Magazine
Health and Wellness In Your 60s
Jody Rawles, MD, professor in the Department of Psychiatry & Human Behavior, offers mental wellness advice for those in their 60s.
UCI School of Medicine Research Insider
August 22, 2023
Aug 22, 2023 | Orange Coast Magazine
Health and Wellness In Your 50s
Jody Rawles, MD, professor in the Department of Psychiatry & Human Behavior, offers mental wellness advice to those in their 50s.
Aug 21, 2023 | The New York Times
What to Know About the New R.S.V. Immunizations
Coleen Cunningham, MD, professor and chair of the Department of Pediatrics talks to The New York Times about antibody therapy for infants.
Aug 21, 2023 | Yahoo Life
Weight-loss medications may help. They also may hurt. Here's what you need to know.
Nathan D. Wong, PhD, professor and director of the Heart Disease Prevention Program in the Division of Cardiology, talks to Yahoo Life about the benefits of weight-loss medications.
Aug 18, 2023 | Healthline
Low-Dose Steroid for Rheumatoid Arthritis Not Linked to Hypertension
Farshid Bozorgnia, MD, assistant professor in the Division of Rheumatology, talks to Healthline about the need for more research on prednisone for rheumatoid arthritis.
Aug 17, 2023 | MDLinx
Your patients are putting castor oil in their eyes. Here's what you need to know.
Donny W. Suh, MD, professor in the Department of Ophthalmology and ophthalmologist at the UCI Gavin Herbert Eye Institute, talks about the risk of putting castor oil in the eyes, as promoted by a recent TikTok trend.
Aug 17, 2023 | UCI News
UCI awarded grant to study sex-specific brain pathway responses to stress
UCI has been awarded a five-year, $3.5 million grant from the National Institute of Mental Health to study the sex-specific differences in circuits that connect the brain’s stress and reward centers.
Aug 16, 2023 | CNBC
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
Nathan D. Wong, PhD, professor and director of the Heart Disease Prevention Program in the Division of Cardiology, talks to CNBC about this recently published study that projects 93 million U.S. adults who are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy.
August 15, 2023